Glaukos Corp (NYSE:GKOS) – Equities research analysts at Piper Jaffray lowered their Q3 2019 EPS estimates for Glaukos in a report released on Wednesday, May 9th. Piper Jaffray analyst M. O’brien now anticipates that the medical instruments supplier will earn $0.02 per share for the quarter, down from their previous forecast of $0.03. Piper Jaffray also issued estimates for Glaukos’ Q4 2019 earnings at $0.02 EPS.
Get Glaukos alerts:Glaukos (NYSE:GKOS) last posted its quarterly earnings results on Wednesday, May 9th. The medical instruments supplier reported ($0.08) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.10) by $0.02. Glaukos had a negative net margin of 2.25% and a positive return on equity of 1.24%. The business had revenue of $40.10 million for the quarter, compared to analysts’ expectations of $37.63 million. During the same period in the prior year, the company posted $0.02 EPS. The business’s revenue for the quarter was up 11.7% on a year-over-year basis.
Top 10 Medical Stocks To Invest In 2019: SunTrust Banks, Inc.(STI)
Advisors' Opinion:- [By Matthew Frankel]
Michael Douglass:�Welcome to Industry Focus, the podcast that dives into a different sector of the stock market every day.�It's�Monday, April 23rd,�and we have a round-up of financials news: yet�another Wells Fargo�fine, Morgan Stanley�(NYSE:MS) and Goldman Sachs�(NYSE:GS) earnings, and a data breach at�SunTrust (NYSE:STI). I'm your host,�Michael Douglass, and I'm joined by Matt Frankel. Matt,�welcome back! Let's hop right in,�because really, quite a bit of interesting news�for us to talk about today. First off,�Wells Fargo was fined $1 billion from the�Consumer Financial Protection Bureau.
- [By Garrett Baldwin] Shares of General Electric Co. (NYSE: GE) are in focus after the company reported earnings before the bell. GE stock popped 5.6% after the firm topped earnings per share (EPS) estimates by $0.05 and backed its 2018 outlook. The firm reported EPS of $0.16 on top of $28.66 billion in revenue. GE stock had been off nearly 18% from its last earnings report on January 24 due to ongoing financial and legal problems. Crude oil prices dipped Friday after U.S. President Donald Trump took aim at OPEC. Trump accused the cartel of keeping oil prices "artificially high" despite "record amounts of oil all over the place." Brent crude and WTI crude oil both hit three-year highs this week after Saudi Arabia suggested that it was working to press oil prices back above $100 per barrel. Three Stocks to Watch Today: PM, MO, WFC Shares of Philip Morris International Inc.�(NYSE: PM) fell this morning after the firm experienced its worst trading day since its spin-off from Altria Group Inc. (NYSE: MO). Shares of PM fell as much as 16% after the firm fell short of revenue expectations after the bell. MO stock fell roughly 6% on the day. Shares of Wells Fargo & Co. (NYSE: WFC) are under pressure after The New York Times reported that the firm may be facing a $1 billion fine. The fines would cover a variety of "alleged" misdeeds that include the firm's push on customers to purchase auto insurance they didn't need and charging mortgage customers fees for services that they were not using. The Consumer Financial Protection Bureau and the Office of the Comptroller of the Currency will most likely announce the fine today. Money Morning�Capital Wave Strategist�Shah Gilani weighed in on the topic this week, and he offers a scorching indictment. Qualcomm Inc. (Nasdaq: QCOM) is on the move today after the semiconductor giant announced plans to lay off 1,500 employees. The cuts are expected to hit employees in California and cities around the globe. The cuts are part of the fi
- [By Logan Wallace]
SunTrust Banks (NYSE:STI) Director Frank P. Scruggs, Jr. purchased 1,000 shares of the stock in a transaction dated Wednesday, May 16th. The shares were acquired at an average price of $69.01 per share, with a total value of $69,010.00. Following the transaction, the director now owns 8,501 shares in the company, valued at $586,654.01. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
- [By Logan Wallace]
Shares of SunTrust Banks (NYSE:STI) have been assigned a consensus recommendation of “Hold” from the twenty-seven ratings firms that are currently covering the company, MarketBeat reports. Eighteen equities research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $70.40.
- [By Motley Fool Staff]
It seems like we're hearing about new data breaches on a regular basis, and SunTrust's (NYSE:STI) recent one affecting 1.5 million customers could seem alarming. Here's what investors -- and consumers -- need to know about it and how this one is different from some of the other high-profile data breaches we've heard about.
Top 10 Medical Stocks To Invest In 2019: Maiden Hldgs Ltd(MHLD)
Advisors' Opinion:- [By Lisa Levin]
Losers Netshoes (Cayman) Limited (NASDAQ: NETS) shares dipped 43.73 percent to close at $2.87 on Tuesday as the company posted downbeat Q1 results. Cesca Therapeutics Inc. (NASDAQ: KOOL) shares dropped 29.01 percent to close at $0.80 after reporting Q1 results. SenesTech, Inc. (NASDAQ: SNES) shares fell 22.2 percent to close at $0.340 after reporting Q1 miss. Vipshop Holdings Limited (NYSE: VIPS) fell 19.95 percent to close at $12.08 after the company reported weaker-than-expected earnings for its first quarter on Monday. Image Sensing Systems, Inc. (NASDAQ: ISNS) fell 19.68 percent to close at $3.775 after reporting earnings were down year over year. First quarter earnings came in flat, down from 4 cents per share in the same quarter of last year. Sales came in at $3.01 million. Boxlight Corporation (NASDAQ: BOXL) dropped 18.47 percent to close at $9.62 on Tuesday after surging 77.44 percent on Monday. ENDRA Life Sciences Inc. (NASDAQ: NDRA) declined 16.21 percent to close at $2.43. ENDRA Life Sciences is expected to release quarterly earnings today. ALJ Regional Holdings, Inc. (NASDAQ: ALJJ) shares fell 16.13 percent to close at $1.79. Switch Inc (NYSE: SWCH) shares dropped 14.93 percent to close at $13.16 following a first-quarter earnings miss. Restoration Robotics Inc (NASDAQ: HAIR) fell 14.42 percent to close at $3.68 after reporting a first-quarter earnings miss. iCAD, Inc. (NASDAQ: ICAD) declined 13.01 percent to close at $3.41 following Q1 results. Intersections Inc. (NASDAQ: INTX) fell 12.44 percent to close at $1.97. Histogenics Corporation (NASDAQ: HSGX) declined 12.24 percent to close at $2.15. AZZ Inc. (NYSE: AZZ) fell 12.1 percent to close at $39.60 following Q3 earnings. Hallador Energy Company (NASDAQ: HNRG) fell 11.1 percent to close at $6.49. Integrated Media Technology Limited (NASDAQ: IMTE) dropped 10.66 percent to close at $16.93 on Tuesday. Myomo, Inc. (NYSE: MYO) slipp - [By Lisa Levin]
Companies Reporting After The Bell Booking Holdings Inc. (NASDAQ: BKNG) is projected to post quarterly earnings at $10.67 per share on revenue of $2.87 billion. CenturyLink, Inc. (NYSE: CTL) is expected to post quarterly earnings at $0.19 per share on revenue of $6.00 billion. Albemarle Corporation (NYSE: ALB) is projected to post quarterly earnings at $1.21 per share on revenue of $803.36 million. Spectra Energy Partners, LP (NYSE: SEP) is estimated to post quarterly earnings at $0.81 per share on revenue of $751.57 million. IAC/InterActiveCorp (NASDAQ: IAC) is expected to post quarterly earnings at $0.8 per share on revenue of $923.80 million. Open Text Corporation (NASDAQ: OTEX) is projected to post quarterly earnings at $0.62 per share on revenue of $691.75 million. Tutor Perini Corporation (NYSE: TPC) is expected to post quarterly earnings at $0.29 per share on revenue of $1.09 billion. Twenty-First Century Fox, Inc. (NASDAQ: FOXA) is projected to post quarterly earnings at $0.54 per share on revenue of $7.41 billion. ICU Medical, Inc. (NASDAQ: ICUI) is estimated to post quarterly earnings at $1.84 per share on revenue of $346.28 million. TechnipFMC plc (NYSE: FTI) is expected to post quarterly earnings at $0.33 per share on revenue of $3.13 billion. Synaptics Incorporated (NASDAQ: SYNA) is projected to post quarterly earnings at $0.91 per share on revenue of $401.76 million. The Dun & Bradstreet Corporation (NYSE: DNB) is expected to post quarterly earnings at $1.07 per share on revenue of $386.91 million. Matrix Service Company (NASDAQ: MTRX) is estimated to post quarterly earnings at $0.07 per share on revenue of $285.16 million. Maiden Holdings, Ltd. (NASDAQ: MHLD) is projected to post quarterly earnings at $0.21 per share on revenue of $739.31 million. tronc, Inc. (NASDAQ: TRNC) is expected to post quarterly earnings at $0.65 per share on revenue of $428.25 million. Copa Holdings,
Top 10 Medical Stocks To Invest In 2019: Macatawa Bank Corporation(MCBC)
Advisors' Opinion:- [By Ethan Ryder]
BidaskClub upgraded shares of Macatawa Bank (NASDAQ:MCBC) from a buy rating to a strong-buy rating in a research note released on Friday morning.
Separately, Hovde Group set a $11.00 price target on Macatawa Bank and gave the stock a hold rating in a research report on Monday, January 29th.
Top 10 Medical Stocks To Invest In 2019: Southern Missouri Bancorp, Inc.(SMBC)
Advisors' Opinion:- [By Joseph Griffin]
Keefe, Bruyette & Woods initiated coverage on shares of Southern Missouri Bancorp (NASDAQ:SMBC) in a research note issued to investors on Thursday. The brokerage issued a market perform rating on the savings and loans company’s stock.
- [By Joseph Griffin]
Southern Missouri Bancorp (NASDAQ: SMBC) and First Connecticut Bancorp (NASDAQ:FBNK) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, risk and dividends.
- [By Joseph Griffin]
Southern Missouri Bancorp (NASDAQ:SMBC) was downgraded by equities researchers at BidaskClub from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Monday.
Top 10 Medical Stocks To Invest In 2019: Glu Mobile Inc.(GLUU)
Advisors' Opinion:- [By Joseph Griffin]
Glu Mobile (NASDAQ:GLUU) insider Masi Niccolo De sold 134,785 shares of Glu Mobile stock in a transaction on Thursday, May 3rd. The shares were sold at an average price of $4.81, for a total value of $648,315.85. Following the completion of the transaction, the insider now owns 524,755 shares of the company’s stock, valued at $2,524,071.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
- [By Rick Munarriz]
Shares of�Glu Mobile�(NASDAQ:GLUU)�hit another two-year high on Wednesday. The mobile games publisher has been on a roll since posting blowout financial results last week. The stock moved 22% higher last week, and it has soared 171% since the start of last year.
- [By Rick Munarriz]
Zoe's Kitchen�(NYSE:ZOES),�Sogou�(NYSE:SOGO), and Glu Mobile�(NASDAQ:GLUU) are three names currently trading on the wrong side of $10, but their prospects are brighter than their sticker prices. Let's go over why they may be among the top stocks under $10.�
Top 10 Medical Stocks To Invest In 2019: Neuberger Berman Real Estate Securities Income Fund, Inc.(NRO)
Advisors' Opinion:- [By Ethan Ryder]
Neuro (NRO) is a PoW/PoS coin that uses the
SHA-256 hashing algorithm. It was first traded on May 18th, 2017. Neuro’s total supply is 55,075,678 coins and its circulating supply is 53,075,678 coins. Neuro’s official Twitter account is @neurocoinnews. The official website for Neuro is neurocoin.org. - [By ]
Neuberger Berman Real Estate Securities Income Fund (NYSE: NRO)
While focusing on primarily the United States, NRO also has limited retail exposure, with just 9.4% allocated to regional malls and 6.7% allocated to shopping centers for a total of just 16.1% retail exposure. For investors seeking low volatility, a 5-year chart of NRO's share price is shockingly similar to the EKG of a cabbage, remaining in a tight band between $5 and $6 a share. The current share price is on the lower end at around $5.15, a 12% discount to NAV, and yields 10.5%.
Top 10 Medical Stocks To Invest In 2019: Mitsubishi Heavy Industries Ltd (MHVYF)
Advisors' Opinion:- [By SEEKINGALPHA.COM]
Major foreign competitors today now include the French firm Areva (OTCPK:ARVCF) and the Japanese firm Mitsubishi Heavy Industry (OTCPK:MHVYF). This is not a complete list but a focus on major players.
Top 10 Medical Stocks To Invest In 2019: CIM Commercial Trust Corporation(CMCT)
Advisors' Opinion:- [By Joseph Griffin]
Crowd Machine (CURRENCY:CMCT) traded 9.6% lower against the US dollar during the 24-hour period ending at 0:00 AM ET on May 14th. Over the last week, Crowd Machine has traded down 49% against the US dollar. One Crowd Machine token can now be bought for approximately $0.0436 or 0.00000499 BTC on exchanges including Coinhub, BitForex and HitBTC. Crowd Machine has a market capitalization of $0.00 and $233,116.00 worth of Crowd Machine was traded on exchanges in the last 24 hours.
- [By Jack Delaney]
CIM Commercial Trust Corp. (NYSE: CMCT) acquires, owns, and operates office properties in the United States.
It has a portfolio of more than 100 buildings that is valued at a combined $25 billion, according to BizJournals.com.
Top 10 Medical Stocks To Invest In 2019: Apricus Biosciences, Inc(APRI)
Advisors' Opinion:- [By William Romov]
California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).
- [By Paul Ausick]
Apricus Biosciences Inc. (NASDAQ: APRI) also dropped about 38% Monday to post a new 52-week low of $0.26. Shares closed at $0.42 on Friday and the stock’s 52-week high is $3.34. Volume was more than three times the daily average of around 1.4 million shares. The company is considering its options after the U.S. FDA directed the firm to develop a new formulation for its erectile dysfunction drug, Vitaros.
- [By Chris Lange]
Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDA��s review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.
Top 10 Medical Stocks To Invest In 2019: NVE Corporation(NVEC)
Advisors' Opinion:- [By Joseph Griffin]
Kayne Anderson Rudnick Investment Management LLC increased its holdings in NVE Co. (NASDAQ:NVEC) by 1.3% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 741,605 shares of the semiconductor company’s stock after purchasing an additional 9,645 shares during the period. Kayne Anderson Rudnick Investment Management LLC owned approximately 15.32% of NVE worth $61,635,000 at the end of the most recent quarter.
- [By Stephan Byrd]
NVE Co. (NASDAQ:NVEC) shares hit a new 52-week high and low on Wednesday . The stock traded as low as $105.88 and last traded at $103.80, with a volume of 52 shares changing hands. The stock had previously closed at $104.57.
Media stories about Oracle (NYSE:ORCL) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Oracle earned a news sentiment score of 0.11 on Accern’s scale. Accern also gave media stories about the enterprise software provider an impact score of 46.8152753525681 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.